zoliflodacin Diastereomer - Request Quote
zoliflodacin Diastereomer
| SZ CAT No: | SZ-Z035007 |
| CAS No | NA |
| Mol.F. | C22H22FN5O7 |
| Mol.Wt. | 487.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
zoliflodacin Diastereomer is chemically (2S,4S,4aS)-11-fluoro-2,4-dimethyl-8-((S)-4-methyl-2-oxooxazolidin-3-yl)-1,2,4,4a-tetrahydro-2'H,6H-spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4',6'(1'H,3'H)-trione. zoliflodacin Diastereomer is supplied with detailed characterization data compliant with regulatory guideline. zoliflodacin Diastereomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of SZ-Z035.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality zoliflodacin Diastereomer
Purchase zoliflodacin Diastereomer
zoliflodacin Diastereomer suppliers
zoliflodacin Diastereomer manufacturers
zoliflodacin Diastereomer price
Order zoliflodacin Diastereomer
Enquire zoliflodacin Diastereomer
zoliflodacin Diastereomer cost
zoliflodacin Diastereomer Supplier
zoliflodacin Diastereomer Distributor
zoliflodacin Diastereomer for Method Validation
SZ-Z035 Reference Standard
zoliflodacin Diastereomer for ANDA Filing
zoliflodacin Diastereomer for Forced Degradation Studies
zoliflodacin Diastereomer Identification Standards
zoliflodacin Diastereomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


